HealthTree News

HealthTree News is a place to learn all about your disease in easy-to-understand language. The site features news articles, patient stories, basics articles, and clinical trial updates with new content every week.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

Flu and Covid-19 Vaccines: Should You Bundle Your Shots This Season?

November 06, 2024

Learn recent research divulging if it's wise for blood cancer patients to bundle their flu and COVID-19 vaccinations this winter season.

Low-Risk MDS Patients See Limited Benefit from Traditional Anemia Treatment (ESAs)

October 30, 2024

Study finds limited benefits of erythropoiesis-stimulating agents for low-risk MDS patients, suggesting a need for new treatments.

MDS Awareness Day: Spotlight on Anemia and Transfusion Independence

October 25, 2024

On MDS Awareness Day, learn how treating anemia aims to reduce transfusions, improve quality of life, and manage complications like iron overload.

Anemia Treatment for Lower-Risk MDS Receives FDA Orphan Drug Designation

October 23, 2024

Learn about tebapivat, a new anemia treatment in clinical trials for those with lower-risk MDS.

RVU120: A New Treatment in Clinical Trials for AML, MDS, and Myelofibrosis

October 22, 2024

What is RVU120, a new medicine in clinical trials, and how may it help reduce signs/symptoms of AML, MDS, and myelofibrosis?

Aplastic Anemia and Myelodysplastic Syndromes: Similarities and Differences

October 18, 2024

Learn about the similarities and differences between aplastic anemia and MDS, including symptoms, diagnosis, treatment options, and support resources.

What is Pancytopenia? Symptoms, Causes, & Treatments

October 11, 2024

Are your blood counts low? It may be pancytopenia. Learn about its causes and treatments.

Risk Categories for Myelodysplastic Syndromes: Understanding IPSS-R

October 10, 2024

The standard tool for risk stratification in patients with MDS is the IPSS-R. This includes diverse features to determine how the disease is likely to progress.

Understanding Bone Marrow Fibrosis in Myelodysplastic Syndromes

October 02, 2024

Bone marrow fibrosis refers to the build-up of scar-like tissue in the bone marrow, which can occur in 10–20% of patients with myelodysplastic syndromes (MDS).